MAUDE Adverse Event Report: LUTONIX, INC LUTONIX 035 DRUG COATED BALLOON PTA CATHETER

Model Number	9004
Medical Device Problem Codes	Restricted Flow rate (1248); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes	Stenosis (2263); Thrombosis/Thrombus (4440); Restenosis (4576)
Date of Event	07/09/2024
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H10: d4 (expiry date: 10/2026).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
Event or Problem Description
It was reported through results of a clinical trial that approximately four months and four days post index procedure using a drug-coated balloon catheter, the subject developed adverse event of decreased flow due to stenosis of juxta-anastomotic region which required reintervention.Reportedly, the adverse event was treated with standard percutaneous transluminal angioplasty and other drug coated balloon.Furthermore, the adverse event was not related to the device and procedure but definitely related to the av access circuit.The current status of the patient is unknown.
Event or Problem Description
It was reported through results of a clinical trial that approximately four months and four days post index procedure using a drug-coated balloon catheter, the subject developed adverse event of decreased flow due to stenosis of juxta-anastomotic region which required reintervention.Reportedly, the adverse event was treated with standard percutaneous transluminal angioplasty and other drug coated balloon.Furthermore, the adverse event was not related to the device and procedure but definitely related to the av access circuit.The re-intervention involved on the target lesion on the cephalic vein with initial stenosis of 51.1% and final residual stenosis of 20%.The re-intervention was successful, and the current status of the patient was unknown.
Additional Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H11: d4 (unique identifier (udi) #), h6 (patient).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
Additional Manufacturer Narrative
H11: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.B5, g3, h6 (patient, method).Section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
Event or Problem Description
It was reported through results of a clinical trial that approximately four months and four days post index procedure using a drug-coated balloon catheter, the subject developed adverse event of decreased flow due to stenosis of juxta-anastomotic region which required reintervention.Reportedly, the adverse event was treated with standard percutaneous transluminal angioplasty and other drug coated balloon.Furthermore, the adverse event was not related to the device and procedure but definitely related to the av access circuit.The re-intervention involved on the target lesion on the cephalic vein with initial stenosis of 51.1% and final residual stenosis of 20%.The re-intervention was successful, additionally thrombosis of the fistula which was dilated along its entire length (including the segment treated with lutonix at baseline) to perform the thrombectomy was reported and it is impossible to determine whether the target lesion is responsible or not and the current status of the patient was unknown.
Additional Manufacturer Narrative
H11: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.B5, g3, h6 (device) section a through f: the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
Event or Problem Description
It was reported through results of a clinical trial that approximately four months and four days post index procedure using a drug coated balloon catheter, the subject developed adverse event of decreased flow due to stenosis of juxta anastomotic region which required reintervention.Reportedly, the adverse event was treated with standard percutaneous transluminal angioplasty and other drug coated balloon.Furthermore, the adverse event was not related to the device and procedure but definitely related to the av access circuit.The re intervention involved on the target lesion on the cephalic vein with initial stenosis of 51.1% and final residual stenosis of 20%.The re intervention was successful, additionally thrombosis of the fistula which was dilated along its entire length (including the segment treated with lutonix at baseline) to perform the thrombectomy was reported and it is impossible to determine whether the target lesion is responsible or not.It was further reported that subject had adverse event of fistulogram revision due to decreased flow due to juxta anastomotic narrowing.The adverse event was not related to the device and procedure but definitely related to the av access circuit.The re intervention involved on the target lesion on the cephalic vein with initial stenosis of 91% and final residual stenosis of 7%.The re intervention was successful.However, current status of the patient was unknown.

• Brand Name: LUTONIX 035 DRUG COATED BALLOON PTA CATHETER
• Common Device Name: DRUG COATED BALLOON PTA CATHETER
• Manufacturer (Section D): LUTONIX, INC; 9409 science center dr; new hope MN 55428
• Manufacturer (Section G): C.R. BARD, INC. (GFO); 289 bay road; queensbury 12804
• Manufacturer Contact: brett curtice ; 800 w. rio salado pkwy; tempe, AZ 85281 ; 4803032689
• MDR Report Key: 19905229
• Report Number: 3006513822-2024-00045
• Device Sequence Number: 8619038
• Product Code: ONU
• UDI-Device Identifier: 00801741123207
• UDI-Public: (01)00801741123207(17)261027(10)GFHX2057
• Combination Product (Y/N): Y
• Initial Reporter State: CA
• Initial Reporter Country: US
• PMA/510(K) Number: P130024
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Other,Study
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup,Followup,Followup
• Report Date (Section B): 02/25/2026

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Model Number: 9004
• Device Catalogue Number: LX351305605F
• Device Lot Number: GFHX2057
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 07/09/2024
• Supplement Date Received by Manufacturer: 10/08/2024; 02/05/2026; 03/09/2026
• Initial Report FDA Received Date: 08/05/2024
• Supplement Report FDA Received Date: 10/17/2024; 02/11/2026; 03/13/2026
• Was Device Evaluated by Manufacturer? (Y/N): No
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 72 YR
• Patient Sex: Male
• Patient Weight: 72 KG
• Patient Ethnicity: Hispanic
• Patient Race: White